Himbacine: Difference between revisions

From WikiMD's Wellness Encyclopedia

No edit summary
 
CSV import
 
Line 1: Line 1:
[[File:Himbacine.svg|Himbacine|thumb]]
{{Short description|An alkaloid with potential pharmacological applications}}
'''Himbacine''' is an alkaloid isolated from the bark of Australian [[magnolia]]s. Himbacine has been synthesized using a [[Diels-Alder reaction]] as a key step.<ref name="pmid11674285">{{cite journal |author=Chackalamannil S, Davies RJ, Wang Y, ''et al.'' |title=Total Synthesis of (+)-Himbacine and (+)-Himbeline |journal=J. Org. Chem. |volume=64 |issue=6 |pages=1932–1940 |date=March 1999 |pmid=11674285|doi=10.1021/jo981983+}}</ref> Himbacine's activity as a [[muscarinic]] [[receptor antagonist]], with specificity for the [[Muscarinic acetylcholine receptor M2]], made it a promising starting point in [[Alzheimer's disease]] research.<ref name="Malaska et al">{{cite journal |doi=10.1016/0960-894X(94)00459-S |author=Malaska MJ, Fauq AH, Kozikowski AP, Aagaard PJ, McKinney M |title=Chemical Modification of Ring C of Himbacine:  Discovery of a Pharmacophoric Element for M2-Selectivity |journal= Bioorganic and Medicinal Chemistry Letters |volume=5 |issue=1 |pages=61–66 |year=1995}}</ref><ref name="pmid15225708">{{cite journal |author=Chackalamannil S, Doller D, McQuade R, Ruperto V |title=Himbacine analogs as muscarinic receptor antagonists-effects of tether and heterocyclic variations |journal=Bioorganic and Medicinal Chemistry Letters |volume=14 |pages=3967–3970 |year=2004 |pmid=15225708 |doi=10.1016/j.bmcl.2004.05.047 |issue=15}}</ref>  The development of a muscarinic antagonist based on Himbacine failed but an analog is now in [[clinical trials]] as a [[thrombin]] receptor antagonist.<ref name="pmid18447380">{{cite journal |author=Chackalamannil S, Wang Y, Greenlee WJ, 'et al.'' |title=Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity |journal=J. Med. Chem. |volume=51 |pages=3061–3064 |year=2008 |pmid=18447380|doi=10.1021/jm800180e |issue=11}}</ref><ref name="urlIn Which I Hate A Wonder Drug. In the Pipeline:">{{cite web |url=http://pipeline.corante.com/archives/2008/05/13/in_which_i_hate_a_wonder_drug.php |title=Blog entry about Himbacine and its history in drug development |format= |work= |accessdate=}}</ref>


== See also ==
'''Himbacine''' is a naturally occurring [[alkaloid]] that has been isolated from the bark of the [[Australian]] tree ''[[Galbulimima belgraveana]]''. This compound has garnered interest due to its potential pharmacological properties, particularly as a [[muscarinic receptor]] antagonist.
* [[Vorapaxar]]
 
==Chemical Structure and Properties==
Himbacine is classified as a [[terpenoid]] alkaloid. Its chemical structure is characterized by a complex polycyclic framework, which includes several [[stereocenters]]. The molecular formula of himbacine is C<sub>21</sub>H<sub>31</sub>NO<sub>2</sub>. The presence of multiple rings and functional groups contributes to its biological activity.
 
==Pharmacological Activity==
Himbacine is primarily known for its activity as a [[muscarinic receptor]] antagonist. It has been studied for its potential to block [[acetylcholine]] at muscarinic receptors, which are a subtype of [[cholinergic receptor]]s. This action can influence various physiological processes, including [[cardiovascular]] function and [[central nervous system]] activity.
 
===Potential Therapeutic Uses===
Due to its muscarinic antagonistic properties, himbacine has been investigated for several therapeutic applications:
 
* '''[[Cardiovascular]] Effects''': Himbacine may have potential in treating certain cardiovascular conditions by modulating heart rate and [[blood pressure]].
* '''[[Neurological Disorders]]''': Its ability to affect the central nervous system suggests possible applications in treating [[neurological disorders]] such as [[Alzheimer's disease]] and [[Parkinson's disease]].
 
==Biosynthesis==
The biosynthesis of himbacine in ''Galbulimima belgraveana'' involves the [[terpenoid]] pathway, which is responsible for the formation of many complex plant alkaloids. The exact biosynthetic steps remain a subject of research, but it is believed to involve the cyclization of [[isoprenoid]] precursors.
 
==Research and Development==
Research into himbacine and its derivatives continues, with studies focusing on its pharmacokinetics, safety profile, and potential for drug development. Synthetic analogs of himbacine are also being explored to enhance its efficacy and reduce potential side effects.
 
==Related Pages==
* [[Alkaloid]]
* [[Muscarinic receptor]]
* [[Cholinergic receptor]]
* [[Galbulimima belgraveana]]
* [[Terpenoid]]


== References ==
{{Reflist}}
{{Cholinergics}}
[[Category:Alkaloids]]
[[Category:Alkaloids]]
[[Category:Naphthofurans]]
[[Category:Muscarinic antagonists]]
[[Category:Piperidines]]
[[Category:Terpenoid alkaloids]]
[[Category:Lactones]]
{{pharmacology-stub}}

Latest revision as of 19:17, 22 March 2025

An alkaloid with potential pharmacological applications


Himbacine is a naturally occurring alkaloid that has been isolated from the bark of the Australian tree Galbulimima belgraveana. This compound has garnered interest due to its potential pharmacological properties, particularly as a muscarinic receptor antagonist.

Chemical Structure and Properties[edit]

Himbacine is classified as a terpenoid alkaloid. Its chemical structure is characterized by a complex polycyclic framework, which includes several stereocenters. The molecular formula of himbacine is C21H31NO2. The presence of multiple rings and functional groups contributes to its biological activity.

Pharmacological Activity[edit]

Himbacine is primarily known for its activity as a muscarinic receptor antagonist. It has been studied for its potential to block acetylcholine at muscarinic receptors, which are a subtype of cholinergic receptors. This action can influence various physiological processes, including cardiovascular function and central nervous system activity.

Potential Therapeutic Uses[edit]

Due to its muscarinic antagonistic properties, himbacine has been investigated for several therapeutic applications:

Biosynthesis[edit]

The biosynthesis of himbacine in Galbulimima belgraveana involves the terpenoid pathway, which is responsible for the formation of many complex plant alkaloids. The exact biosynthetic steps remain a subject of research, but it is believed to involve the cyclization of isoprenoid precursors.

Research and Development[edit]

Research into himbacine and its derivatives continues, with studies focusing on its pharmacokinetics, safety profile, and potential for drug development. Synthetic analogs of himbacine are also being explored to enhance its efficacy and reduce potential side effects.

Related Pages[edit]